Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Davinder Ramsingh

Anesthesiology Orange, CA Medical Doctor

NPI 1235257999 CMS profile 1298374

101 The City Dr S, Ste 300, Orange, CA 92868

Open in the dashboard

General payments

$54,524

56 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$4,500

1 holding reported · through program year 2025

Research they led as principal investigator

$177,253 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Davinder Ramsingh of Orange, CA is reported in the CMS Open Payments database as having received $54,524 across 56 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $177,253 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $4,500 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,200 1
2024 General $418 2
2023 General $373 2
2022 General $3,375 7
2020 General $12,917 20
2019 General $33,241 24
2019 Ownership $4,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Davinder Ramsingh
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Davinder Ramsingh were reported at $4,200. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Davinder Ramsingh Anesthesiology median Middle half National median
2019 $33,241 $72 $23–$151 $163
2020 $12,917 $36 $17–$120 $114
2021 $0 $49 $21–$135 $132
2022 $3,375 $52 $22–$144 $149
2023 $373 $53 $23–$143 $160
2024 $418 $55 $25–$150 $164
2025 $4,200 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $26,940 40 payments
  2. Ge Healthcare $17,606 6 payments
  3. Butterfly Network, Inc. $6,199 2 payments
  4. FUJIFILM SonoSite, Inc. $2,000 1 payment
  5. EchoNous, Inc. $945 1 payment
  6. Becton, Dickinson and Company $768 3 payments
  7. Aerie Pharmaceuticals, Inc. $44 2 payments
  8. Celgene Corporation $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $33,584 30 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,688 3 payments
  3. Travel and Lodging $2,646 7 payments
  4. Gift $1,999 1 payment
  5. Food and Beverage $608 15 payments
Products named General payments · program years 2019–2025
  1. X-Porte Ultrasound System $2,000 1 payment
  2. Butterfly iQ $1,999 1 payment
  3. Kosmos $945 1 payment
  4. Rhopressa $44 2 payments
  5. ZEPOSIA $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$13,604

Medicare's payments for the services billed

Medicare patients

50

Average age 71

Services billed

68

21 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 66%
Ischemic heart disease 48%
Arthritis 46%
Chronic kidney disease 44%
Heart failure 42%
Atrial fibrillation 30%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record